Vasopharm
A company developing therapeutics for acute inflammatory central nervous system conditions
5
Funding Rounds
$35.0m
Money raised
Overview
A company developing therapeutics for acute inflammatory central nervous system conditions
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ul**** Wa**** | - | - | - |
| Ha**** Sc***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Vasopharm has raised a total of $24.3m in funding over 5 rounds.
Key Insights:
- Vasopharm Series F round: $6.5m
- Vasopharm Series D round: $6m
- Vasopharm Series B round: $11.8m
- vasopharm GmbH funding round, July 2019: $10.7m
Vasopharm Series F round
$6.5m
Vasopharm Series D round
$6m
Vasopharm Series B round
$11.8m
vasopharm GmbH funding round, July 2019
$10.7m
Industries
Vasopharm is active in the following industries: